Spina Bifida


Introduction  
Epidemiology  
Embryology and Etiology  
Spectrum of defects  
Associated conditions  
Diagnosis  
  Neonatal assessment and management  
  Initial investigations  
  Differential Diagnosis  
Initial surgical management  
  Operative approach
  Post-operative care
  Figure 1 – spina bifida care pathway
Post-operative complications
  Management of Chiari II problems
  Musculoskeletal management
  Gastrointestinal management
  Integumentary problems
  Latex allergy
  Urologic management
Prognosis
Other spinal dysraphisms
  Meningocele
  Lipomeningocele
  Occult spinal dysraphism – tethered cord syndrome
Recommendations
Reference List
Clinical cases
Questions

Introduction
Spina bifida (SB) is the term used for a spectrum of congenital neural tube defects (NTDs). Other terms used for these anomalies are spinal dysraphisms or myelodysplasias. NTDs are complex medical problems which challenge surgeons and paediatricians alike, both in their initial management and in their life-long complications. While SB may become a vanishing disease in developed countries, it remains a very significant cause of morbidity and disability in the developing world.

Epidemiology
The key epidemiologic features of SB are: wide regional and ethnic differences in prevalence, a world-wide decline in prevalence over the past 3 decades, and female preponderance (1). The reasons behind the decline are unclear and most likely multi-factorial, though both folic acid supplementation / fortification and selective termination of pregnancies are key factors (2). The range in prevalence in Western nations is roughly 0.1 – 1 per 1,000 live births; a few non-Western studies often quote higher rates, though again widely spread.(3-5)

Embryology and Etiology
Spina bifida may result either from failure of closure of the neural tube, or from secondary re-opening of a closed tube, although most of the evidence favours the former theory. (6)
The etiology of SB is multi-factorial (1). Evidence for a genetic component is evidenced by the familial risk. This appears to be 20-50 per 1,000 if one child is affected, 100 per 1,000 if 2 children are affected, and 30 per 1,000 if the mother is over 35 years of age (2). Environmental factors include low socio-economic factors, maternal hyperthermia, and medications. The latter include primarily carbamazepine, valproic acid, and folate. The use of carbamazepine and valproic acid causes a 1% risk of SB infants in mothers taking them.
Folic acid, on the other side, has been conclusively shown to both prevent the first occurrence of SB defects in pregnant women and to cause a 70% reduction in recurrent SB in mothers who already had pregnancies with NTDs (7). Based on the overwhelming evidence for folic acid importance in preventing NTDs, folate supplementation of at least 400 µg daily has been uniformly recommended for all women of child-bearing age. However, the difficulty in reaching this wide group at risk makes food fortification a much better method, adopted in most developed countries. (8) This policy, if implemented fully, is expected to result in a 50% reduction in NTDs. Unfortunately, only 10% African countries have been able to implement this policy (9).

Spectrum of defects
The obvious (apparent) spinal defects include myelomeningoceles, meningoceles (together referred to as spina bifida cystica), and lipomeningoceles. Occult lesions include diastematomyelia (split cord), tight filum terminale, dorsal dermal sinus, and spinal lipoma. The term spina bifida occulta should be reserved for spinal bone fusion defects only.

Associated conditions
Children with SB frequently have associated congenital anomalies. These include primarily renal and orthopaedic problems, which will be discussed later. Other associations are undescended testes in males and anorectal anomalies. In fact up to 50% of children with anorectal anomalies have a tethered cord (6).
The main neurological association with SB is the Chiari II malformation, present in most cases of SB (2). Rather than a single anomaly, this is in fact a constellation of brain and spinal cord anomalies specifically associated with SB. Its key feature is hindbrain (cerebellum, pons, medulla) herniation into the cervical canal, and is responsible for the frequent hydrocephalus (HC) in children with spina bifida (6;10).
Other neurological associations of SB are tethered cord (discussed later) and syringomyelia. The latter is a dilation of the central canal of the cord with CSF, and is found asymptomatically in most patients with SB (2).

Diagnosis
Prenatal screening for SB includes maternal AFP, acetylcholinesterase, and ultrasound (1). In utero treatment for the spinal defect remains experimental (11), and for the associated hydrocephalus is associated with an unacceptable mortality (6). The effect of mode of delivery (vaginal vs. cesarian section) on neurological defect is controversial and remains under study (1).

Neonatal assessment and management
The patient born with an open SB defect must be managed with immediate saline coverage of the defect, prone positioning, and the start of intravenous antibiotics. Neurotoxic iodine-based solutions should not be applied to the defect. The physical assessment of the child needs to be comprehensive, as listed in the table below.

Physical Examination of the child with spina bifida

The appearance of the spinal defect reveals its identity: myelomeningoceles usually have a central “open” defect without normal skin, often with a visible placode (the open spinal cord). They may appear flat at birth, then often fill up with CSF. Older unoperated children will often have significant scarring, and the skin may indeed completely close the defect. Meningoceles and lipomeningoceles are fully skin covered from birth, with the former typically cystic and the latter fatty in consistency.
The distribution of the levels of SB depends on referral patterns and access to care, but usually about 40% are lumbosacral, 30% lumbar, and 30% thoracic or thoracolumbar. (12) The accurate assessment of the spinal cord function is critical. It must be kept in mind that the skin level of the defect may not accurately reflect the spinal level, that children may exhibit both upper and lower motor neuron lesions, and that the level may be asymmetrical.
Hydrocephalus occurs in 80-90% of infants with spina bifida (1), but may not be apparent until the spinal defect is closed. It is less frequently seen in children with sacral defects. Our experience as well as other reports may point to a lower incidence of hydrocephalus in developing countries. (12)
The Chiari II malformation may also cause specific hindbrain herniation symptoms in about 20% of SB children. These symptoms include apnea, a high-pitch cry, and swallowing difficulties (2;6).

Initial investigations
There are no immediate investigations that are required in a regular case of SB. Spinal X-rays may reveal other occult dysraphisms in 10% of patients (6), though this will likely not affect the management. Magnetic resonance (MR) imaging of the spine is frequently performed in developed nations, though hardly necessary if resources are limited. An ultrasound of the head for hydrocephalus is useful, though the ventriculomegaly may not be evident until the CSF leak through the spinal defect is closed. There are several investigations for the GU system which will be discussed under that heading.

Differential diagnosis
The differential diagnosis of SB is limited. Sacrococcygeal teratomas may mimic large sacral neural defects, though their appearance is usually more heterogeneous, they have no open placode and often surround the anal canal. Lipomas of the midline back may mimic lipomeningoceles, and therefore require spinal XRs and even MR imaging to exclude an association with the spinal canal.


Initial surgical management
The management of a child with spina bifida is lengthy and complex (2;13). The closure of the spinal defect is the most obvious step, though it is by far not the most challenging one. While major associated congenital anomalies may lead to a palliative approach without surgery, the level of the defect should not affect that decision. While some have advocated in the past a selective approach to SB (14;15), there is good evidence that a non-selective approach yields equally good results compared with a selective approach, while giving a chance for life to many more children (2;16). In fact the overall mortality and the intelligence quotients (IQs) of the unselected groups compare favourably with that of the “best” infants from the selected group (2). Looked at differently, 60% of the children from the selected group, who were allowed to die, would have been “competitive” if allowed to survive (2).
On the other side, occasional older asymptomatic children coming with relatively small defects which are fully skin-covered and mostly scarred may not need to have their defect “closed”, especially as the surgery in those instances can be very difficult and dangerous. Such children will however need to be carefully followed up for the appearance of tethered cord symptoms and signs.
In the newborn with SB the spinal defect should be closed ideally within the first 2 days, though delays within the first week of life while the child is on antibiotics do not seem to affect adversely the outcome (1). In developing countries children typically present after the first week of life (12;17), and the defect is often grossly infected. While preoperative intravenous antibiotics are the rule in all settings, there is little advantage to lengthy preoperative courses of antibiotics and dressings.

Operative approach
The standard repair of an open SB includes the following steps (2;6;18):

  1. incision of the sac or of the skin surrounding the placode;
  2. circumferential isolation of the placode with removal of all keratinized areas as well as the superficial granulation tissue;
  3. tubularization of the placode with a running monofilament fine suture to reduce the raw surface and re-create a tubular cord;
  4. lysis of all adhesions to the cord both proximally and distally;
  5. circumferential dissection of dura with overlying fatty tissue, down to central region of defect;
  6. watertight dural closure with one layer of running fine monofilament suture;
  7. wide undermining of skin and subcutaneous tissues laterally;
  8. “fascial” closure with interrupted absorbable suture at original junction between skin, dura and defect covering;
  9. skin closure with no tension.

Variations to the above steps may include:

  1. no tubularization of placode if technically difficult;
  2. division of a thickened filum terminale and correction of diastematomyelia, if found;
  3. resection of placode and transection of the cord in cases with full paraplegia, especially if infection is present and the cord is severely atrophic/dysplastic;
  4. irrigation and intrathecal injection of antibiotic (usually gentamycin);
  5. transverse dural closure proximally only if the cord has been transected and longitudinal closure may be difficult;
  6. optional kyphectomy if severe kyphosis prevents good closure;
  7. use of relaxing incisions, rotation or advancement flaps for skin closure if primary closure is too difficult.
    Our personal experience with over 600 SB closures has shown that skin flaps are almost never necessary and often prone to infection. We have also never needed to resort to dural replacements, which are both very costly and risky in the face of infection.

Postoperative care
The multitude of interventions in the immediate post-operative care are illustrated in figure 1 – the spina bifida care pathway used at our institution. Such protocolized care facilitates team care and improves outcomes.

Post-operative complications
Wound problems are frequent, including infection, dehiscence, and necrosis (12;14;18). They can be managed almost always conservatively with dressings, debridement, and sitz baths. CSF leaks may occur (12;12), and although most will resolve with time and control of the CSF pressure (with shunting or acetazolamide), persistent leaks may require re-exploration.
Re-tethering of the cord at the repair site occurs in 15-20% of cases long-term (6), and requires prompt surgical untethering.

Management of Chiari II problems
While concomitant shunting for HC at the time of the neonatal spinal defect closure is standard in developed nations, the approach must differ in the developing world. In our experience and that of others in Africa, early shunting leads to frequent shunt infection and ventriculitis. Our practice is to wait at least a week after the spinal closure for shunting, or longer if there is any evidence of wound infection. Mild stable hydrocephalus with a cortical mantle of at least 3.5cm can be observed safely for several months without deleterious effects (2).
Other Chiari II symptoms and signs (apnea, stridor, poor swallowing) are initially managed by decreasing the intra-cerebral pressure (ICP) through shunting (6). Persistent symptoms may require a posterior fossa decompression (2;6), though this procedure is challenging and should be reserved to specialized centres.

Musculoskeletal management
Scoliosis and/or kyphosis are the most common orthopaedic associations of SB. They develop in up to 60% of children with SB (12), especially in children with thoracic defects (2). Seating appliances can help, but braces are of questionable value and surgical management (spinal fusion) is very challenging.
Talipes equinovarus (TEV, club foot) is the next most common orthopaedic problem (12). Ideally it is treated conservatively though casting in the neonatal period, while, later on, a postero-medial release may be required (19). Other lower extremity problems include high arch foot deformity, leg discrepancy, flat foot, foot valgus, and congenital dislocation of the hip (12).
Adults with SB appear to develop multiple degenerative musculoskeletal problems including osteoarthritis and osteoporosis.
Depending on the motor level, patients with SB may require a variety of orthotic devices to allow partial or full ambulation. These include above- and below-knee braces, crutches, walkers, and wheelchairs (2). Traditional teaching states that independent ambulation is possible if the quadriceps are strong (L3-4), but long-term studies have shown that the mobility of children with SB decreases with age despite stable neurological status (2;6).

Gastrointestinal management
Nutritional problems are frequent in the SB population. While in developed nations obesity from limited activity is common, many children with SB in the developed world suffer from nutritional deficiencies.
Defecation problems are however the main challenge in this population. (20;21) Constipation occurs predominantly in children with high lesions, due to slow colonic transit, and in children with sacral lesions, because of deficient rectal sensibility (22). Constipation may be managed through dietary manipulation combined with regular finger stimulation or manual evacuation.
Fecal incontinence is much more of a challenge, with at least half of children being affected(12;22). Children with lumbosacral lesions often have pellet-like stools from slow left colonic transit, evacuated without voluntary control despite fair sphincter function. They are best managed with intentional constipating foods and daily manual evacuation. School-age children who fail this regimen should first be tried on retrograde washouts every 1-3 days (22;23). The next step is the ACE procedure (antegrade colonic enemas)(23;24). In this procedure the child’s colon is cleaned daily with a small volume of water and/or paraffin administered through a cutaneous appendicostomy. In developed countries this procedure has been modified to use a small cecostomy “button” device inserted under radiographic guidance (25). The standard cutaneous appendicostomy however is quite effective and well-suited for the developing world.

Integumentary problems
Decubitus ulcers occur frequently in patients with SB, especially beyond the age of 5 years (12). They represent therapeutic challenges. Similarly to ulcers in other patients with neurological deficits, a conservative approach with saline dressings and avoidance of pressure areas is always warranted. Refractory ulcers can benefit from plastic surgical procedures, though recurrences are frequent.
Other ulcers in these patients are found in the perineal area and are caused by urinary and/or stool incontinence. These ulcers must be managed by attempting to address the underlying incontinence problems.

Latex allergy
Latex allergy is an IgE-mediated problem leading to the spectrum of urticaria, bronchospasm, and anaphylaxis. While latex allergy is a frequent (20-30%) complication in children with SB in developed countries (26;27), it is rarely reported in the developing world and also in our own experience. Some evidence from South Africa suggest a lower overall incidence compared to western nations (28).

Urological management
Spina bifida is the main cause of neurogenic bladder dysfunction, which leads to hydronephrosis, vesico-ureteric reflux (VUR), and ultimately renal failure. (29;30) One half of untreated patients with SB will experience these complications, which in fact constitute the main cause of mortality in this population (31).
The bladder dysfunction in SB patients can be classified by the interplay between the bladder and sphincter muscles in 3 groups: synergic (both muscles acting in unison, 19%); dyssynergic with/out detrusor hypertonicity (DSD) (45%), and denervated (36%).
The basic urological work-up of patients with SB includes renal ultrasound, serum creatinine, and volume urodynamics. These include leak-point pressure (LPP) and post-void residual (PVR) values, both measured using a simple burette and 3-way stopcock apparatus (32). More sophisticated electromyography (EMG) urodynamics are not necessary in most instances.
The mainstay in the treatment of the neurogenic bladder of children with SB is clean intermittent catheterization (CIC). This procedure is simple to perform and to teach in all patient groups, cheap, safe (33), and very efficient. It has revolutionized urological care in SB and is well suited for resource-poor settings. It is most efficacious when started in infancy, though it can be started at any point in time. It is performed by the main caregiver of the child until the age of 6-7 years, after which self-catheterization can be taught (33). In our institution we perform volume urodynamics 3 days after the closure of the spinal defect, then immediately teach the caregivers to perform CIC if the volumetric criteria are met. These include an LPP = 30cm or a PVR = 10cc (32). Other criteria we use include laboratory evidence of renal dysfunction (abnormal renal ultrasound, creatinine or urinalysis), recurrent urinary tract infections, and the need to promote social continence in older children.
CIC may need to be complemented with medications. These are detrusor overactivity relaxants such as oxybutinin and imipramine, administered either orally or intravesically.
CIC with or without medications will prevent renal deterioration in 90% of children with SB, and achieve social continence in about 85% (2). Only a minority of patients should require urological procedures, such as bladder augmentation, bladder neck reconstruction, or urinary diversion (30;34;35). However, long-term renal follow-up is essential in all SB patients. We advise yearly renal ultrasound and volumetric urodynamics. While in developed countries renal transplantation is ultimately the treatment of choice for renal failure (31), this is rarely an option in developing countries.

Prognosis
The mortality in patients with SB appears to be between 25-50% into adulthood (2;27), and naturally higher in developing countries. Renal failure is a common cause of late mortality, as well as sepsis and shunt complications (36).
Over 85% of the patients have ventriculoperitoneal shunts, with most of them having undergone at least one revision (27). A third of the patients have undergone a tethered cord release, and half have scoliosis. The same long-term Western study however showed that 85% of patients are attending or have graduated from high school and/or college, and more than 80% have social bladder continence (27). Another British study found a 50% mortality after 30 years, while among the survivors 70% had an IQ of 80 or more, 37% lived independently in the community, 39% drove a car, 30% could walk more than 50 meters and 26% were in formal employment (37).
Results from developing countries are rather scanty. A Nigerian study found that 40% of children with myelomeningoceles were “functionally disabled” and could not be adequately rehabilitated because of limited resources (14). The authors therefore advocated a selective management. A South African study revealed a 70% ambulation rate, 45% urinary continence, and a mean IQ of 80 (17). As expected, their results were better in urban areas and in the higher socio-economic groups. Our own experience has shown that 64% of children with SB over the age of five had some from of independent mobility.
Interestingly, quality of life in SB appears strongly influenced not only by neurological characteristics, but also by “soft” factors such as parental hope.

Other spinal dysraphisms
Meningocele
Meningoceles are defects of the dura, arachnoid, and dural pouches without neural elements (6). They arise primarily posteriorly, though anterior and lateral defects are also seen. The affected children will therefore be mostly intact neurologically, and the incidence of HC is also low (though not nil). Intra-operatively often a fibrous stalk is found connecting the underlying cord to the cyst wall, and this needs to be totally excised to prevent re-tethering.

Lipomeningocele
This is another occult dysraphic state, formed by a partial dorsal myeloschisis with a lipoma fused to the dorsal aspect of open cord. It is caused by the inner neural tube inducing mesenchyme to differentiate into fat (38). Clinically it is similar to the meningocele in being fully skin-covered, though its consistency often reveals the fatty composition. Neurological deficits are usually absent at birth, appear after the second year of life, and affect most patients by early childhood (6). Patients are typically referred for a fatty mass in the midline lower back, occasionally extending into one buttock. Half of the patients have an associated cutaneous marking (38).
While the appearance may not be very impressive, these defects are notoriously difficult to repair, as the lipomatous tissue is intricately associated with the nerve roots and the dura. A magnetic resonance (MR) scan is very important in revealing the extent of the abnormality (6). While a partial resection is possible and may help cosmesis, it is inappropriate as the tethering of the cord remains. Lipomeningoceles are not surgical emergencies and therefore should only be repaired in specialized centers using operative magnification. Repair entails proximal laminectomy, careful dissection of the fatty tissue with untethering of the cord, and dural reconstitution for closure (6). Post-operative CSF leaks are frequent in our experience.

Occult spinal dysraphisms – tethered cord syndrome
There is a wide spectrum of other occult spinal dysraphisms, including intradural lipoma, diastematomyelia, tight filum terminale, dermoid cyst/sinus, aberrant nerve roots, anterior sacral meningocele, and cauda equina tumor (6). They are relatively rare conditions, though it is known that up to one third of the population has occult spinal defects (39).
Most occult dysraphisms are signaled by cutaneous abnormalities, such as dimples, tufts, sinuses, vascular malformations, or lipomas (12;12;40). The patients may be totally asymptomatic, though many will develop a tethered cord syndrome with age, particularly during significant growth spurts. Most symptoms are musculoskeletal (high arch, abnormal toes, leg discrepancy, abnormal gait) and urological.
A tethered cord syndrome (41) must be therefore suspected and ruled out whenever a patient of any age develops new or progressive weakness and/or spasticity, a deteriorating gait, change of bowel/bladder function, back or leg pain, progressive scoliosis or foot deformity (6). While there may be significant pain, the neurologic signs and musculoskeletal deformities (especially lordoscoliosis and contractures) may be subtle. Occasionally, a change in urodynamic studies in a patient with previously repaired SB may be the first clue.
Confirmation of the clinical diagnosis of tethered cord requires MR, and the treatment is prompt surgical untethering.


Recommendations

  1. folic acid can prevent half of the cases of spina bifida, and therefore efforts should be made to supplement folic acid to the diet of all women of child-bearing age. As this is very difficult in developing nations, policies for folic acid fortification of common foods should be actively pursued.
  2. all children with spina bifida should be thoroughly examined for associated conditions, including hydrocephalus, musculoskeletal, genito-urinary, gastrointestinal, and skin problems.
  3. initial investigations need only include head ultrasound and postoperative renal evaluation.
  4. a non-selective approach to the treatment of spina bifida leads satisfactory results in developing nations and can be adopted if the resources are available.
  5. most spina bifida defects in Africa present beyond 48 hours of life, and must therefore be considered infected.
  6. surgical repair may include transection of the cord, excision of the placode and proximal dural closure in severe paraplegic cases.
  7. dural replacements and skin flaps must be avoided because of the infection risk.
  8. shunting for hydrocephalus, if needed, should be delayed by at least one week after the closure of the spina bifida defect, because of infection risk.
  9. the long-term management of children with spina bifida is complex and requires multi-disciplinary resources – therefore these children should as much as possible be treated or referred to centers able to provide the necessary care.
  10. the key impact on the long-term survival of children with spina bifida is proper urological management, including urodynamic evaluation, clean intermittent catheterization (CIC) and detrusor overactivity relaxants. CIC is effective, cheap, and feasible in developing nations.
  11. lipomeningoceles are not urgent conditions and their repair is very challenging – they should therefore be referred to specialized centers.
  12. any child with progressive lower extremity, bladder or bowel symptoms should be assessed for possible tethered cord syndrome and promptly treated.

Dan Poenaru MD, MHPE, FRCSC, FACS, FICS, FCS-ECSA
Adjunct Professor of Surgery and Paediatrics, Queens’ University, Kingston, Canada
Hon. Professor of Surgery, Aga Khan University, Nairobi, Kenya
Medical Education & Research Director, AIC Kijabe Hospital
Kijabe, Kenya

Save review as .PDF


Reference List

Reference Text

  1. Park TS. Myelomeningocele. In: Albright L., Pollack I., Adelson D., editors. Principles and Practice of Pediatric Neurosurgery. New York: Thieme Medial Publishers, 1999: 291-320.
  2. Dias MS, Dias MS. Neurosurgical management of myelomeningocele (spina bifida). Pediatrics in Review 2005; 26(2):50-60.
  3. Airede KI, Airede KI. Neural tube defects in the middle belt of Nigeria. Journal of Tropical Pediatrics 1992; 38(1):27-30. (12 kb)
  4. Kulkarni ML, Mathew MA, Reddy V, Kulkarni ML, Mathew MA, Reddy V. The range of neural tube defects in southern India. Archives of Disease in Childhood 1989; 64(2):201-204. (53 kb)
  5. Msamati BC, Igbigbi PS, Chisi JE, Msamati BC, Igbigbi PS, Chisi JE. The incidence of cleft lip, cleft palate, hydrocephalus and spina bifida at Queen Elizabeth Central Hospital, Blantyre, Malawi. Central African Journal of Medicine 2000; 46(11):292-296. (13 kb)
  6. Kaufman BA. Neural tube defects. Pediatric Clinics of North America 2004; 51(2):389-419. (563 kb)
  7. Lumley Jea. Preconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews 2006; 1 (2006). (247 kb)
  8. Oakley GPBKNWMB. Recommendations for Accelerating Global Action to Prevent Folate-Preventable Birth Defects and other Folate-deficiency Diseases. Birth Defects Research 2004; 70:235-237. (71 kb)
  9. Unicef: The Micronutrient Initiative. Vitamin and mineral deficiency - a global damage assessment report. 2004. Ref Type: Report (80 kb)
  10. McLone DG, Dias MS, McLone DG, Dias MS. The Chiari II malformation: cause and impact. Childs Nervous System 2003; 19(7-8):540-550. (787 kb)
  11. Northrup H, Volcik KA, Northrup H, Volcik KA. Spina bifida and other neural tube defects. Current Problems in Pediatrics 2000; 30(10):313-332. (1 766 kb)
  12. Kumar R, Singh SN, Kumar R, Singh SN. Spinal dysraphism: trends in northern India. Pediatric Neurosurgery 2003; 38(3):133-145. (1 403 kb)
  13. Dias L, Dias L. Orthopaedic care in spina bifida: past, present, and future. Developmental Medicine & Child Neurology 2004; 46(9):579. (40 kb)
  14. Shehu BB, Ameh EA, Ismail NJ, Shehu BB, Ameh EA, Ismail NJ. Spina bifida cystica: selective management in Zaria, Nigeria. Annals of Tropical Paediatrics 2000; 20(3):239-242. (245 kb)
  15. Lorber J, Lorber J. Results of treatment of myelomeningocele. An analysis of 524 unselected cases, with special reference to possible selection for treatment. Developmental Medicine & Child Neurology 1971; 13(3):279-303.
  16. Hunt GM, Hunt GM. Open spina bifida: outcome for a complete cohort treated unselectively and followed into adulthood. Developmental Medicine & Child Neurology 1990; 32(2):108-118. (1 295 kb)
  17. Buccimazza S, Molteno C, Dunne T, Buccimazza S, Molteno C, Dunne T. Pre-school follow-up of a cohort of children with myelomeningocele in Cape Town, South Africa. Annals of Tropical Paediatrics 1999; 19(3):245-252. (531 kb)
  18. McLone DG, Dias MS, McLone DG, Dias MS. Complications of myelomeningocele closure. Pediatric Neurosurgery 1991; 17(5):267-273. (14 kb)
  19. Flynn JM, Herrera-Soto JA, Ramirez NF, Fernandez-Feliberti R, Vilella F, Guzman J et al. Clubfoot release in myelodysplasia. Journal of Pediatric Orthopaedics, Part B 2004; 13(4):259-262. (166 kb)
  20. Doolin E. Bowel Management for patients with Myelodysplasia. Surg Clin N Am 2006; 86:505-514. (189 kb)
  21. Lemelle JLeal. A multicentre study of the management of disorders of defecation in patients with spina bifida. Neurogastroenterol Motil 2006; 18:123-128. (63 kb)
  22. Rintala RJ, Rintala RJ. Fecal incontinence in anorectal malformations, neuropathy, and miscellaneous conditions. Seminars in Pediatric Surgery 2002; 11(2):75-82. (744 kb)
  23. Christensen P, Kvitzau B, Krogh K, Buntzen S, Laurberg S, Christensen P et al. Neurogenic colorectal dysfunction - use of new antegrade and retrograde colonic wash-out methods. Spinal Cord 2000; 38(4):255-261. (140 kb)
  24. Ekmark E, Adams RC, Ekmark E, Adams RC. The antegrade continence enema (ACE) surgical procedure: patient selection, outcomes, long-term patient management. European Journal of Pediatric Surgery 2000; 10 Suppl 1:49-51.
  25. Chait PG, Shandling B, Richards HF, Chait PG, Shandling B, Richards HF. The cecostomy button. Journal of Pediatric Surgery 1997; 32(6):849-851. (1739 kb)
  26. Obojski A, Chodorski J, Barg W, Medrala W, Fal AM, Malolepszy J et al. Latex allergy and sensitization in children with spina bifida. Pediatric Neurosurgery 2002; 37(5):262-266. (382 kb)
  27. Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA, Bowman RM et al. Spina bifida outcome: a 25-year prospective. Pediatric Neurosurgery 2001; 34(3):114-120. (538 kb)
  28. Johar A, Lim DL, Arif SA, Hawarden D, Toit GD, Weinberg EG et al. Low prevalence of latex sensitivity in South African spina bifida children in Cape Town. Pediatric Allergy & Immunology 2005; 16(2):165-170. (116 kb)
  29. Carr MC. Bladder Management for Patients with Myelodysplasia. Surg Clin N Am 2006; 86:515-523. (215 kb)
  30. Lemelle JL, Guillemin F, Aubert D, Guys JM, Lottmann H, Lortat-Jacob S et al. A multicenter evaluation of urinary incontinence management and outcome in spina bifida. Journal of Urology 2006; 175(1):208-212. (72 kb)
  31. Muller T, Arbeiter K, Aufricht C, Muller T, Arbeiter K, Aufricht C. Renal function in meningomyelocele: risk factors, chronic renal failure, renal replacement therapy and transplantation. Current Opinion in Urology 2002; 12(6):479-484. (76 kb)
  32. Jeruto A, Poenaru D, Bransford R. Clean intermittent catheterization: overview of results in 194 patients with spina bifida. African J Paed Surg 1:20-3, 2004. African Journal of Paediatric Surgery 2004; 1(1):20-23. (40 kb)
  33. Campbell JB, Moore KN, Voaklander DC, Mix LW, Campbell JB, Moore KN et al. Complications associated with clean intermittent catheterization in children with spina bifida. Journal of Urology 2004; 171(6 Pt 1):2420-2422. (77 kb)
  34. Aslan AR, Kogan BA, Aslan AR, Kogan BA. Conservative management in neurogenic bladder dysfunction. Current Opinion in Urology 2002; 12(6):473-477. (70 kb)
  35. Gonzalez R, Schimke CM, Gonzalez R, Schimke CM. Strategies in urological reconstruction in myelomeningocele. Current Opinion in Urology 2002; 12(6):485-490. (80 kb)
  36. McDonnell GV, McCann JP, McDonnell GV, McCann JP. Why do adults with spina bifida and hydrocephalus die? A clinic-based study. European Journal of Pediatric Surgery 2000; 10 Suppl 1:31-32. (15 kb)
  37. Oakeshott P, Hunt GM, Oakeshott P, Hunt GM. Long-term outcome in open spina bifida. British Journal of General Practice 2003; 53(493):632-636. (72 kb)
  38. Naidich TP, McLone DG, Mutluer S, Naidich TP, McLone DG, Mutluer S. A new understanding of dorsal dysraphism with lipoma (lipomyeloschisis): radiologic evaluation and surgical correction. AJR 1983; American Journal of Roentgenology. 140(6):1065-1078. (5 920 kb)
  39. Fidas A, MacDonald HL, Elton RA, Wild SR, Chisholm GD, Scott R et al. Prevalence and patterns of spina bifida occulta in 2707 normal adults. Clinical Radiology 1987; 38(5):537-542. (105 kb)
  40. Guggisberg D, Hadj-Rabia S, Viney C, Bodemer C, Brunelle F, Zerah M et al. Skin markers of occult spinal dysraphism in children: a review of 54 cases. [erratum appears in Arch Dermatol. 2005 Apr;141(4):425]. Archives of Dermatology 2004; 140(9):1109-1115. (213 kb)
  41. Michelson DJ, Ashwal S, Michelson DJ, Ashwal S. Tethered cord syndrome in childhood: diagnostic features and relationship to congenital anomalies. Neurological Research 2004; 26(7):745-753. (13 kb)

Save review as .PDF

Questions

Click here to join the Surgery in Africa Discussion Group

(Back to Top)

Previous Review
Surgery in Africa Home
Next Review Article